UK Biomaterials in Healthcare Market Report 2022 to 2030

UK Biomaterials in Healthcare Market Analysis

$ 3999

The UK Biomaterials Healthcare Market is expected to witness growth from $4.06 Bn in 2022 to $9.49 Bn in 2030 with a CAGR of 11.20% for the forecasted year 2022-2030. In the UK, the prevalence of chronic illnesses like osteoarthritis, diabetes, and cardiovascular disease is rising. The demand for biomaterials in the healthcare sector is being driven by the ability to use them to make medical implants and devices that can aid in the management of these diseases. The market is segmented by type and by application. Some key players in this market include Camstent, Renovos Biologics, Collagen Solutions, BASF SE, Celanese, and Evonik Industries.

ID: IN10GBMD003 CATEGORY: Medical Devices GEOGRAPHY: UK AUTHOR: Jigyasu Bhandari

Buy Now

UK Biomaterials in Healthcare Market Executive Analysis

The UK Biomaterials Healthcare Market size is at around $4.06 Bn in 2022 and is projected to reach $9.49 Bn in 2030, exhibiting a CAGR of 11.20% during the forecast period. In 2022, healthcare accounted for about 45% of all UK government expenditures on goods and services. The typical citizen pays about 4.5% of their income, or about 18% of their income tax, towards healthcare. The typical percentage of the UK's gross domestic product that is spent on healthcare is 8.4%.

In the UK, Materials created specifically to interact with biological systems are identified as biomaterials. They are frequently used to create medical devices, implants, and drug delivery systems in the healthcare sector. Orthopaedic devices, including plates, screws, and joint replacements, are frequently made from biomaterials. Patients with conditions like arthritis or fractures may benefit from these gadgets to help them regain mobility and lessen their discomfort. Dental implants, which can substitute missing teeth and enhance oral health, are also made with the aid of biomaterials. Many cardiovascular devices, including stents and heart valves, are made with biomaterials. The risk of heart disease can be decreased and blood flow can be improved with the aid of these devices. A wound dressing that promotes recovery and prevents infection can be made using biomaterials.

UK Biomaterials Healthcare Market Analysis

Market Dynamics

Market Growth Drivers

In the UK, the prevalence of chronic illnesses like osteoarthritis, diabetes, and cardiovascular disease is rising. The demand for biomaterials in the healthcare sector is being driven by the ability to use them to make medical implants and devices that can aid in the management of these diseases. An ageing populace in the UK is driving up demand for biomaterials-based medical equipment and implants. People may need joint replacements, dental implants, or other biomaterials-based technologies as they live longer. Innovation in the UK healthcare sector is being driven by developments in biomaterials technology. More biocompatible, long-lasting, and adaptable than ever before new biomaterials are being created, opening up new business possibilities for manufacturers. New biomaterials technologies are being developed with financing from the UK government, which gives manufacturers access to capital. For instance, the government's Industrial Strategy Challenge Fund is spending money on biomaterials industry R&D.

Market Restraints

In the UK, the availability and cost of certain biomaterials for manufacturers may be impacted by the need for particular raw materials, which may be in short supply. It may be challenging for new entrants to obtain market share because established players currently control the majority of the biomaterials healthcare market. Smaller manufacturers may find it more difficult to develop and compete in the industry as a result.

Competitive Landscape

Key Players

Camstent (UK)
Renovos Biologics (UK)
Collagen Solutions (UK)
BASF SE
Celanese
Covestro AG
Evonik Industries

Notable Recent Deals

2021: To use its patented dCELL technology in the creation of a new regenerative medicine product for tendon and ligament repair, Tissue Regenix Group plc revealed in 2021 that it had entered into a licencing agreement with Medtronic US-based medical device company.

Healthcare Policies and Regulatory Landscape

The UK has a strong regulatory system in place for biomaterials. The UK's Medicines and Healthcare Products Regulatory Agency (MHRA), which is supervised by the Department of Health and Social Services, is in charge of overseeing biomaterials regulations. Medical devices that use biomaterials are subject to a strict regulatory process that includes evaluation of their efficacy, safety, and quality. Manufacturers may be required to acquire a CE mark, which certifies that the product complies with the EU's Medical Devices Regulation, depending on the device's risk classification. In accordance with the UK-EU Trade and Cooperation Agreement, the UK ratified the EU's Medical Devices Directive in 2021.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the UK market in 2019. The growing geriatric population UKly is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.